Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BRIM Biotechnology Inc.
DescriptionRecombinant protein based on the adenovirus serotype 3 fiber knob
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today